The Honest Company enters its third-quarter report with an unusual problem for a turnaround story: management has already told investors that the good news will look a little less good for a while. After raising its full-year targets for revenue, gross margin and adjusted EBITDA last quarter, the company also warned that marketing spending would climb roughly 20% in the back half and that SG&A investments would ramp. That leaves the November 5 report as a test of whether Honest can absorb heavier reinvestment without blurring the case that its business is now structurally more profitable.

Wall Street's bar is low on the bottom line. Consensus calls for breakeven EPS, down from $0.01 a year ago and well below the $0.04 Honest earned last quarter, while the whisper number sits a penny higher at $0.01. That gap is too thin to signal much enthusiasm, but it does suggest the market expects Honest to at least cover its stepped-up spending. Revenue is projected at $80.8 million, a 12.8% decline from $92.6 million a year earlier and a dip from the $83.3 million reported last quarter. That contraction is mostly self-inflicted, reflecting strategic exits rather than demand erosion, so the headline number matters less than organic growth underneath it.

Guidance is where the setup gets interesting. Management lifted its 2026 revenue outlook to $319 million to $325 million from $306 million to $312 million, yet consensus for the year sits at about $309 million, below the bottom of the new range. Part of the raise reflects a roughly $10 million benefit from liquidating apparel inventory, which analysts may be discounting as low-quality revenue. Still, the Street is effectively betting management overshot. A quarter that keeps Honest on track for the range would force those estimates higher; a soft print would vindicate the skeptics.

The operating narrative from last quarter hinged on several threads that should now show up in the numbers. Organic growth accelerated to 6.7% from 3.9%, consumption grew around 8% against a category growing about 2%, and household penetration climbed to 8.1%, with two-thirds of the gains coming from households without children. Wipes and personal care, now more than 70% of revenue, are the engine, helped by the flushable wipes campaign, new CVS placement and the Toy Story kids line moving into grocery chains such as HEB and Ahold Delhaize. Sustained high-single-digit consumption and continued penetration gains would confirm the raised 5% to 7% organic growth target. Any fade toward the low single digits would suggest the first half benefited from easier comparisons. Diapers, which management now calls a structurally pressured category, are a shrinking drag, but steeper-than-expected declines could still weigh on the total.

Margins are the other proof point. Underlying adjusted gross margin hit roughly 44% last quarter, and management guided to mid-40s for the year, helped by warehouse consolidation savings arriving ahead of schedule. Holding gross margin near that level while marketing ramps would show the efficiency gains are durable. Investors should also check free cash flow, since management flagged that part of the first half's $35.3 million inflow came from inventory timing that will partially reverse.

Sentiment has swung from 26.6% bearish heading into the last report to a modestly bullish 8.8%, yet the stock tells a cooler story. Shares have slipped 3.7% since the last report, lagging a flat S&P 500, and at $4.71 trade near the bottom of the post-earnings range of $4.46 to $6.01, though comfortably above the 200-day average of $3.74. The post-report spike faded, meaning the market liked the raise but has not fully bought it. The central issue is whether organic momentum and gross margin hold firm enough to show that the second-half profit dip is deliberate investment rather than an early sign that the inflection is losing steam.